Topics

Companies Related to "Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration" [Most Relevant Company Matches] RSS

10:50 EST 21st February 2020 | BioPortfolio

Here are the most relevant search results for "Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration" found in our extensive corporate database of over 50,000 company records.

Showing "Decellularised Dermis Allograft Treatment Chronic Venous Ulceration" Companies 1–25 of 4,000+

Relevant

Venarum Medical, LLC

Venarum Medical is a privately held medical device company that develops endovascular solutions to challenging vascular conditions such as deep vein chronic venous insufficiency (CVI). The EndoVenous Valve System is designed to provide an endovascular prosthetic venous valve implant that functionally replaces dysfunctional native venous valves. The EndoVenous Valve System operates throughout the ...


Tractus Vascular, LLC

Chronic total occlusion (CTO) remains one of the most challenging pathologies encountered by surgeons and interventionists in performing endovascular interventions. CTO in the arterial vasculature is characterized by heavy arteriosclerotic plaque burden resulting in complete, or near complete occlusion of a vessel. The reported rate of CTO in patients who undergo treatment of symptomatic peripher...

InterVene Inc.

InterVene Inc. has developed the first non-implantable, catheter-based, vein valve creation therapy. The product is designed to treat chronic venous insufficiency (CVI) in the deep veins - a severely under-treated disease that causes painful venous stasis ulcers and other debilitating symptoms in millions of Americans annually. For more information, visit www....


Vnus Medical Technologies

VNUS Medical Technologies, Inc. is dedicated to providing innovative products for treatment of venous disease. Our mission is to help patients look and feel better with safe, fast and more effective treatments for venous disease. VNUS Medical Technologies, founded in 1995, is a public company and world leader in the development and commercialization of products for minimally invasive treatment of...

Lotus Tissue Repair, Inc.

Lotus Tissue Repair, Inc. is developing its proprietary recombinant collagen type VII (rC7) technology as a treatment for dermatologic conditions in which rC7 may play an important role in accelerating chronic wound healing, such as diabetic foot ulcers, venous stasis ulcers and similar conditions. The company’s lead program is the first and only prot...

Sapheon Inc.

Sapheon is an early stage medical device company whose mission is to develop new approaches for the treatment of vascular disease. Our current focus is on developing technology to improve the treatment of venous reflux disease. Sapheon's newly developed vein closure technology responds to the inadequacies of existing venous reflux treatment options by usin...

Vesper Medical, Inc.

Vesper Medical is a privately held medical device company advancing the treatment of deep venous disease and creating a highly differentiated, purpose-built venous stent portfolio to address the multiple anatomical challenges presented by the iliac and femoral veins. Vesper Medical is a spinout of Intact Vascular, Inc., a company dedicated to innovation in ...

Venous Disease Coalition

The Venous Disease Coalition (VDC) is an alliance of more than 35 leading health professional societies and patient advocacy groups that have united around a common goal: To improve the survival rates and quality of life for individuals with, or at risk for, venous disease. The VDC plans to develop a national campaign to educate public and health care professionals in the U.S. about venous disease...

Tactile Medical

Tactile Medical headquartered in Minneapolis, MN is a leader in lymphedema and venous ulcer therapies, serving tens of thousands of patients throughout the U.S. The home therapy device company manufactures and provides products for patients with chronic edema, including the Flexitouch® System, an advanced pneumatic compression device and Entré System...

Ultradian Diagnostics LLC

Ultradian is a medical device company developing wireless, wearable biosensors for monitoring chronic illnesses. The Company was founded to improve the accuracy of minimally invasive biosensors so they may be used at the bedside in hospitals and by people for self-monitoring of chronic illnesses. Ultradian's initial product, called Biologue, is a minimally...

Synergy Health Concepts

The team at Pacific Interventionalists launched Synergy Health Concepts to focus specifically on CCSVI treatment and care. Chronic Cerebro-Spinal Venous Insufficiency (CCSVI) is characterized by veins that are not adequately able to carry blood from the brain and central nervous system to the heart. Synergy performs various procedures to help relieve CCSVI...

CorMedix Inc.

CorMedix Inc. is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac and renal dysfunction, also known as cardiorenal disease. CorMedix’s goal is to treat kidney disease by reducing the commonly associated cardiovascular and metabolic complications, in effect, tr...

Medical Components, Inc.

Medical Components, Inc. (aka Medcomp, Inc.) is headquartered in Harleysville, PA and is the Vascular Access Industry’s leading manufacturer and innovator of high quality and high performance vascular access catheters and accessories. Medcomp offers Chronic, Acute and Peritoneal Dialysis Catheters, Peripherally Inserted Central Catheters (PICCs), Infu...

EnzySurge Ltd

EnzySurge Ltd. is a developer and provider of innovative solutions for the treatment and management of chronic wounds. EnzySurge's DermaStream(R) platform offers a new and unique wound treatment modality by continuously streaming a fresh supply of advanced therapeutic solutions to a controlled wound environment. DermaStream is designed to deliver effective, affordable and easy-to-use wound tre...

Advanced Neuromodulation Systems

Welcome to Advanced Neuromodulation Systems Successful treatment of a chronic pain or neurological condition begins with expanding your knowledge and exploring your options.Welcome to Advanced Neuromodulation Systems where our neurostimulation and drug pump technologies are advancing treatment standards for chronic pain and neurological disorders, broadening treatment choices for patients and phys...

Ascendant Neuro

For the past 15 years, Ascendant Neuro has successfully conducted minimally invasive pain treatment techniques through the innovative use of neurostimulators. Ascendant Neuro's trained physicians, which treat chronic pain of the spine as well as chronic migraine headaches, use neurostimulation to eliminate the symptoms of migraine and chronic head pain.

Adheris, Inc.

Over the last 80 years, the disease burden imposed on Western nations has shifted from acute life-threatening illnesses to chronic degenerative disorders. Today, the leading causes of morbidity and mortality in the U.S. are chronic diseases such as hypertension, high cholesterol, asthma, and diabetes. The effects of chronic diseases often accumulate slowly over decades. Consequently, the burden o...

Stealth Therapeutics Inc.

Stealth Therapeutics was founded in 2006 for the purpose of designing and developing a portfolio of improved venous access devices. The technology is derived from the clinical practice of the company’s founder, Dr. Bradley Glenn. Dr. Glenn, a practicing interventional radiologist with strong interest and experience in venous access devices, guides Ste...

Centrexion Therapeutics Corp.

Centrexion Therapeutics Corp. is focused on advancing the treatment of chronic moderate to severe pain with one of the largest, exclusively pain-focused pipelines of non-opioid, non-addictive therapies in active development. Centrexion Therapeutics recognizes the needs of over a quarter of a billion people living with chronic pain worldwide, and aims to de...

Centrexion Therapeutics, Corp.

Centrexion Therapeutics, Corp. is focused on advancing the treatment of chronic moderate to severe pain with one of the largest exclusively pain-focused pipelines of non-opioid, non-addictive therapies in active development. Centrexion Therapeutics recognizes the needs of over a quarter of a billion patients living with chronic pain worldwide, and ...

Taxus Cardium Pharmaceuticals Group Inc.

Taxus Cardium Pharmaceuticals Group Inc. is a holding company that operates Cardium Therapeutics, a development stage advanced regenerative therapeutics company focused on the late-stage clinical and commercial development of regenerative medicine therapeutics including: (1) Generx®, an interventional cardiology, angiogenic gene therapy product candidate ...

Centrexion Therapeutics Corporation

Centrexion Therapeutics Corp. is focused on advancing the treatment of chronic moderate to severe pain with one of the largest exclusively pain-focused pipelines of non-opioid, non-addictive therapies in active development. Centrexion Therapeutics recognizes the needs of over a quarter of a billion people living with chronic pain worldwide, and aims ...

Rainbow Medical

Rainbow Medical, a private operational investment company, currently holds a portfolio of 12 companies that are developing products for the treatment of a range of chronic indications such as heart disease, diabetes, hypertension, blindness, uterine fibroids, chronic neuropathic pain, and others.

Regeneration Technologies

Regeneration Technologies, Inc. is a leader in tissue-based innovations that are used to repair and promote the natural healing of human bone and other human tissues. RTI processes human musculoskeletal and other tissues, including bone, cartilage, tendon, ligament, pericardial and cardiovascular tissue in producing allograft implants. Surgeons then implant these allografts to repair a wide variet...

Venous Health Systems, Inc.


More From BioPortfolio on "Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration"

Quick Search

Corporate Database Quicklinks